Alcor Life Extension Foundation – Trademark Portfolio
Entity Type: 99
Alcor Life Extension Foundation holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 5 filings in this category. The portfolio also extends into Class 40 (Treatment & Processing) across 3 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include A, DART, ALCOR, THE THIRD WAY, and THE WORLD LEADER IN CRYONICS. The owner is based in Scottsdale, AZ.
7895 East Acoma Drive, Suite 110
Scottsdale, AZ 85260
Showing of trademarks Trademarks
Trademark Classifications
Alcor Life Extension Foundation's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Alcor Life Extension Foundation have?
Alcor Life Extension Foundation has 6 U.S. trademarks filed with the USPTO. Of these, 6 registered.
What trademark classes does Alcor Life Extension Foundation file in?
Alcor Life Extension Foundation files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 40 (Treatment & Processing), Class 39 (Transportation & Storage). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Alcor Life Extension Foundation's most well-known trademarks?
Alcor Life Extension Foundation's registered trademark portfolio includes well-known marks such as A, DART, ALCOR, THE THIRD WAY, and THE WORLD LEADER IN CRYONICS. These are among 6 currently registered trademarks in the portfolio.
What is Alcor Life Extension Foundation's trademark registration success rate?
Alcor Life Extension Foundation has a 100% trademark registration rate, with 6 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.